Evidence map›Paper›PMID 41186063›Full record

ArticleJournal of cosmetic dermatology2025

Moose Technique: A New Anatomical Perspective Treatment in Botulinum Toxin.

Nabil Fakih-Gomez, Cristina Muñoz-Gonzalez

Abstract read
In one paragraph

Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nabil Fakih-GomezDepartment of Surgery, University of Salamanca, Salamanca, Spain.
Cristina Muñoz-GonzalezDepartment of Surgery, University of Salamanca, Salamanca, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBotulinum toxin injections have transformed aesthetic treatments, improving patient confidence and emotional well-being. Eyebrow position plays a vital role in facial expression, yet botulinum toxin use in the forehead can cause issues like eyebrow ptosis or asymmetry. Recent research emphasizes the importance of a comprehensive pre-treatment assessment. The MOOSE technique, developed by the authors, incorporates new insights into muscle interactions to optimize botulinum toxin treatment for brow elevation while minimizing side effects like the omega sign.

methodsThis study involved 202 patients (89.1% female, mean age 40) treated with the MOOSE technique, focusing on upper third facial wrinkles. Primary outcomes included brow position, forehead line severity, treatment duration, and patient satisfaction. Aesthetic outcomes were assessed using the Merz Aesthetic Scales (MAS) at baseline and at two weeks post-treatment, corresponding to the peak efficacy of the toxin. Patient satisfaction was evaluated at both the two-week and four-month follow-up.

resultsThe MOOSE technique resulted in a significant improvement in brow position, with an average gain of 2 points on the MAS. Patient satisfaction was remarkably high, with 100% of patients reporting a positive outcome at 15 days and 99% at four months. The average botulinum toxin dosage was 66 units per patient (range: 54-78 units). No cases of brow or eyelid ptosis were observed, and only one patient (0.49%) experienced transient edema. Interrater reliability of evaluations was excellent, with intraclass correlation coefficients ranging from 0.94 to 1.00 across all measured outcomes.

conclusionThe MOOSE technique provides an anatomically guided approach to botulinum toxin injections, enhancing aesthetic results while reducing complications. Its effectiveness underscores the value of individualized treatment based on muscle dynamics. Further research is needed to refine its application and assess long-term effects.

Indexed as

Botulinum Toxins, Type ACosmetic TechniquesNeuromuscular AgentsSkin AgingAdultAgedEstheticsEyebrowsFacial MusclesFemaleForeheadHumansInjections, IntramuscularMaleMiddle AgedPatient SatisfactionBotulinum Toxins, Type ANeuromuscular Agentsbotulinum toxindynamic wrinklesincobotulinumtoxinAinjection techniqueMOOSE techniquesad face

Identifiers

PMID41186063
PMCPMC12584049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.